IDYA

IDYA

USD

IDEAYA Biosciences Inc. Common Stock

$30.240+0.800 (2.717%)

Цена в режиме реального времени

Healthcare
Биотехнология
Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$29.440

Максимум

$30.450

Минимум

$28.840

Объем

0.19M

Фундаментальные показатели компании

Рыночная капитализация

2.7B

Отрасль

Биотехнология

Страна

United States

Статистические данные торговли

Средний объем

1.21M

Биржа

NMS

Валюта

USD

52-недельный диапазон

Минимум $13.45Текущая $30.240Максимум $33.64

Связанные новости

PR Newswire

IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, provided a business update and announced financial results...

Просмотреть больше
IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
PR Newswire

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...

Просмотреть больше
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PR Newswire

IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...

Просмотреть больше
IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events
Analyst Upgrades

JP Morgan Maintains Overweight on IDEAYA Biosciences, Raises Price Target to $79

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences with a Overweight and raises the price target from $74 to $79.

Просмотреть больше
JP Morgan Maintains Overweight on IDEAYA Biosciences, Raises Price Target to $79
Analyst Upgrades

Goldman Sachs Maintains Neutral on IDEAYA Biosciences, Raises Price Target to $30

Goldman Sachs analyst Corinne Jenkins maintains IDEAYA Biosciences with a Neutral and raises the price target from $27 to $30.

Просмотреть больше
Goldman Sachs Maintains Neutral on IDEAYA Biosciences, Raises Price Target to $30
Analyst Upgrades

RBC Capital Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $41

RBC Capital analyst Leonid Timashev maintains IDEAYA Biosciences with a Outperform and raises the price target from $38 to $41.

Analyst Upgrades

BTIG Reiterates Buy on IDEAYA Biosciences, Maintains $62 Price Target

BTIG analyst Justin Zelin reiterates IDEAYA Biosciences with a Buy and maintains $62 price target.

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.